SGK1 inhibitor compounds and their use for the treatment of neurodegenerative and / or cardiovascular diseases
CA3330167A1Pending Publication Date: 2026-11-05CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC) +1
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- CA3330167
- Authority / Receiving Office
- CA · CA
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-05-22
- Filing Date
- 2025-05-22
- Publication Date
- 2026-11-05
Abstract
The present invention relates to a series of compounds with an indazole structural core, which are capable of inhibiting the SGK1 enzyme. Accordingly, the invention also relates to the use of these compounds to treat neurodegenerative and / or cardiovascular diseases involving this enzyme, such as Parkinson's disease, Alzheimer's disease, myocardial infarction or high blood pressure.
Need to check novelty before this filing date? Find Prior Art
